Loading…
AN2 Therapeutics, Inc. is projected to rise to $6.80 by 2027, a +27% move from its current price of $5.35. ANTX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/2/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 3 | $5.19 | $5.35 | $5.52 | +0.08% |
| Aug 4 | $5.13 | $5.36 | $5.60 | +0.16% |
| Aug 5 | $5.08 | $5.36 | $5.66 | +0.24% |
| Aug 6 | $5.04 | $5.37 | $5.71 | +0.32% |
| Aug 7 | $5.01 | $5.37 | $5.76 | +0.40% |
| Aug 8 | $4.98 | $5.38 | $5.80 | +0.48% |
| Aug 9 | $4.95 | $5.38 | $5.85 | +0.56% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.95 | $5.38 | $5.85 | +0.56% |
| Week 2 | $4.81 | $5.41 | $6.08 | +1.12% |
| Week 3 | $4.71 | $5.44 | $6.28 | +1.68% |
| Week 4 | $4.63 | $5.47 | $6.46 | +2.25% |
| Week 5 | $4.57 | $5.50 | $6.62 | +2.82% |
| Week 6 | $4.51 | $5.53 | $6.78 | +3.39% |
| Week 7 | $4.47 | $5.56 | $6.93 | +3.96% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
AN2 Therapeutics, Inc. is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics. Its portfolio includes boron chemistry programs and research in oncology and infectious disease.
The company’s initial candidate epetraborole is in phase 3 clinical trials as a once-daily oral treatment for non-tuberculous mycobacterial lung disease, and AN2 is studying its use for acute melioidosis. AN2-502998 (AN15368) is an investigational boron-based small molecule in preclinical development for chronic Chagas disease. The company has license agreements with Anacor Pharmaceuticals, Brii Biosciences Limited, and GSK plc to research, develop, manufacture, and commercialize compounds including epetraborole for various human diseases.
AN2 Therapeutics was incorporated in 2017 and is headquartered in Menlo Park, California.
ANTX is the trading symbol for AN2 Therapeutics, Inc. and the current price is $5.33 per share. The company has a market capitalization of $191.97M and is ranked 3601 by market capitalization.
A major floor 44.5% below — a decisive break under it would weaken the trend.
The nearest floor, 19.6% below — buyers have tended to step in here.
Price is pressing into resistance (0.9% away) — a breakout level to watch.
A major ceiling 14.3% above — clearing it would confirm fresh momentum.
Key ANTX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ANTX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.07 | Buy | $5.14 | Buy |
| MA 10 | $4.99 | Buy | $5.01 | Buy |
| MA 20 | $4.77 | Buy | $4.89 | Buy |
| MA 50 | $4.68 | Buy | $4.65 | Buy |
| MA 100 | $4.40 | Buy | $4.13 | Buy |
| MA 200 | $2.80 | Buy | $3.32 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 64.44 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 174.20 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.05 | Buy |
| ROC (12) | 14.56 | Buy |
| Bollinger %B (20,2) | 1.03 | Sell |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.23 | Buy |
| Awesome (5,34) | 0.22 | Buy |
| Ultimate (7,14,28) | 71.08 | Sell |
| Momentum (10) | 0.67 | Buy |
| Aroon Osc (25) | 72.00 | Buy |
| Hull MA (9) | 5.21 | Buy |
| ADX (14) | 13.57 | Neutral |
| ATR (14) | 0.14 | Info |
The near-term technical picture is bullish. RSI on 14 days is 60, indicating modest positive momentum. The 50-day simple moving average stands at $4.66, while the 200-day simple moving average is $2.78. Support is identified at $4.30 and resistance at $5.40. The stock has traded in a 30-day range from $4.31 up to $6.60.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.03 | $5.35 | $7.33 | 0% | Neutral | |
| $5.35 | $6.80 | $9.17 | +27% | Bullish | |
| $7.74 | $10.16 | $14.31 | +90% | Bullish | |
| $8.96 | $12.09 | $17.60 | +126% | Bullish | |
| $9.65 | $13.34 | $19.95 | +149% | Bullish | |
| $10.95 | $15.47 | $23.70 | +189% | Bullish | |
| $10.86 | $15.67 | $24.53 | +193% | Bullish | |
| $12.30 | $18.09 | $28.86 | +238% | Bullish | |
| $14.53 | $21.77 | $35.34 | +307% | Bullish | |
| $16.31 | $24.89 | $41.07 | +365% | Bullish | |
| $22.78 | $37.67 | $66.55 | +604% | Bullish | |
| $52.05 | $99.21 | $193.41 | +17.5x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $1.03 | $5.35 | $6.53 | +0.00% |
| September 2026 | $4.59 | $5.45 | $6.67 | +1.87% |
| October 2026 | $4.80 | $5.75 | $7.13 | +5.53% |
| November 2026 | $4.92 | $5.93 | $7.43 | +3.19% |
| December 2026 | $4.79 | $5.80 | $7.33 | -2.24% |
Click any year to see its month-by-month ANTX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect ANTX to range from $1.03 to $7.33 through 2026. The $5.35 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The ANTX price prediction for 2027 points to an average of $6.80 (low $5.35, high $9.17) — a potential gain of +27% on today's $5.35. Buyers look set to stay in control over this stretch.
In 2028, ANTX is projected to trade between $7.74 and $14.31, averaging $10.16 — a potential gain of +90% from today's $5.35. That is up +49% on the projected 2027 average. Momentum favours further upside here.
AN2 Therapeutics, Inc.'s 2029 outlook centres on $12.09, within a $8.96 to $17.60 range. That is up +19% on the projected 2028 average. That marks a +126% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, ANTX could reach as high as $19.95, with a base case around $13.34 and support toward $9.65 — roughly +149% from $5.35. Momentum favours further upside here.
Expect ANTX to range from $10.95 to $23.70 through 2031. The $15.47 average target implies a +189% move from current prices. That is up +16% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The ANTX price prediction for 2032 points to an average of $15.67 (low $10.86, high $24.53) — a potential gain of +193% on today's $5.35. Momentum favours further upside here.
In 2033, ANTX is projected to trade between $12.30 and $28.86, averaging $18.09 — a potential gain of +238% from today's $5.35. That is up +15% on the projected 2032 average. Buyers look set to stay in control over this stretch.
AN2 Therapeutics, Inc.'s 2034 outlook centres on $21.77, within a $14.53 to $35.34 range. That is up +20% on the projected 2033 average. That marks a +307% change versus current levels. Momentum favours further upside here.
By 2035, ANTX could reach as high as $41.07, with a base case around $24.89 and support toward $16.31 — roughly +365% from $5.35. Buyers look set to stay in control over this stretch.
Expect ANTX to range from $22.78 to $66.55 through 2040. The $37.67 average target implies a +604% move from current prices. That is up +51% on the projected 2035 average. Momentum favours further upside here.
The ANTX price prediction for 2050 points to an average of $99.21 (low $52.05, high $193.41) — a potential gain of +17.5x on today's $5.35. Buyers look set to stay in control over this stretch.
Investing $1,000 in ANTX today (≈ 186.915888 ANTX) could be worth
$18,544.75
+$17,544.75 (+1754%) by 2050 · US Dollar
Based on the average projected ANTX price of $99.21 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ANTXwould be worth at today's price.
$1,000 invested in ANTX on Jul 31, 2025 (≈ 943.396277 ANTX) would be worth
$5,047.17
+$4,047.17 (+404.7%) today · 5.05× · US Dollar
Based on a ANTX entry price of $1.06 vs. today's $5.35.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.92 | $1,087.4 | +8.7% |
| 1 month ago | $4.7 | $1,138.3 | +13.8% |
| 3 months ago | $4.68 | $1,143.16 | +14.3% |
| 6 months ago | $1.12 | $4,776.79 | +377.7% |
| 1 year ago | $1.06 | $5,047.17 | +404.7% |
| All time (4.4y) ago | $15.4 | $347.4 | -65.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ANTX forecast.
Our base-case forecast reaches $11.00 around 2029.
Implied market cap at $11.00: $396.18M
The multi-year forecast shows a clear uptrend in the average price with a bullish sentiment in later years. For 2026, the average is $5.33 with a 0% ROI and neutral sentiment. By 2027 the average is $6.62 with a 24.1% ROI and bullish sentiment, and by 2028 the average is $9.82 with an 84.2% ROI.
In 2029 the average is $11.60 with a 117.6% ROI, and by 2030 the average is $12.70 with a 138.2% ROI. The forecast continues higher through 2031 ($14.58, 173.6%), 2032 ($14.59, 173.7%), 2033 ($16.74, 214%), 2034 ($19.90, 273.3%), 2035 ($22.61, 324.1%), and reaches 2040 at $33.60 average with a 530.4% ROI, and 2050 at $87.11 average with a 1534.4% ROI. The sentiment is bullish across the longer horizon.
These figures are estimates and are not guarantees, reflecting potential paths under varying conditions and milestones.
Tap a question to reveal the answer.
Avg $12.70 with a range from $9.12 to $19.13 and a projected ROI of 138.2%, sentiment BULLISH.
Forecasts show a neutral start in 2026 (Avg $5.33, ROI 0%) and a progression to bullish in later years (e.g., 2030 Avg $12.70, ROI 138.2%; 2040 Avg $33.60, ROI 530.4%; 2050 Avg $87.11, ROI 1534.4%). These are estimates, not guarantees.
Yes. The 2040 forecast lists a max of $60.01 with an average of $33.60 and a ROI of 530.4%.
Current price is $5.33 and market capitalization is $191.97M.
2026: Avg $5.33, Min $1.03, Max $7.26, ROI 0%, Neutral. 2027: Avg $6.62, Min $5.19, Max $8.98, ROI 24.1%, Bullish. 2028: Avg $9.82, Min $7.44, Max $13.91, ROI 84.2%, Bullish. 2029: Avg $11.60, Min $8.54, Max $16.99, ROI 117.6%, Bullish. 2030: Avg $12.70, Min $9.12, Max $19.13, ROI 138.2%, Bullish.
AN2 Therapeutics, Inc. Community Discussion
0Share your AN2 Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.